HCA Holdings (HCA) PT Lowered to $88 at Jefferies; Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Credit Suisse Assumes HCA Holdings (HCA) at Outperform
November 3, 2017 2:26 AM EDTCredit Suisse assumes coverage on HCA Holdings (NYSE: HCA) with a Outperform rating and a price target of $95.00.
For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.
Shares of HCA Holdings closed at $76.43 yesterday.
... MoreHCA Holdings (HCA) PT Lowered to $82 at Piper Jaffray Following 3Q
November 1, 2017 9:04 AM EDTPiper Jaffray lowered its price target on HCA Holdings (NYSE: HCA) to $82.00 (from $86.00) while maintaining a Overweight rating following the company's 3Q earnings report. HCA reported 3Q17 results in-line with the disappointing preannouncement driven by the strong hurricane season, weaker volumes and higher expense... More
HCA Holdings (HCA) PT Lowered to $79 at Morgan Stanley
November 1, 2017 8:55 AM EDTMorgan Stanley lowered its price target on HCA Holdings (NYSE: HCA) to $79.00 (from $85.00) while maintaining a Equalweight rating.
... MoreHCA Holdings (HCA) Misses Q3 EPS by 72c, Miss on Revenues; FY17 EPS Outlook Below Consensus
October 31, 2017 8:33 AM EDTHCA Holdings (NYSE: HCA) reported Q3 EPS of $1.21, $0.72 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $11.13 billion.
Key third quarter metrics (all percentage changes compare 3Q 2017 to 3Q 2016 unless noted):
Revenues increased 4.2 percent to $10.696 billionNet income attributable to HCA Healthcare, Inc. totaled $426 million, or $1.15 per diluted shareAdjusted EBITDA totaled... More